| Literature DB >> 34966812 |
Ya-Nan Mo1, Feng Cheng1,2, Zhen Yang1, Xiao-Fei Shang1, Jian-Ping Liang1, Ruo-Feng Shang1, Bao-Cheng Hao1, Xue-Hong Wang1, Hong-Juan Zhang1, Ahmidin Wali2, Chun-Fang Lu2, Yu Liu1,3.
Abstract
The fruits of Ailanthus altissima Swingle (AS) possess a variety of pharmacological activities. Its antioxidant activity and the potential mode of action have not yet been investigated. In in vitro studies, AS revealed the strong reducing power and DPPH scavenging effect, but hydroxyl radical scavenging activity and ferrous ions-chelating ability were not strong. Meanwhile, the oxidative stress RAW264.7 cell injury model was established, the low and medium-doses of AS showed significant protective effects on the viability of H2O2-treated cells by CCK-8 method. Besides, three doses of AS all increased the activities of SOD, CAT, and GSH-Px and decreased the MDA level compared with the H2O2 group, suggesting it significantly relieved oxidative stress of cells. The active ingredients and related targets of AS were collected by HERB and Swiss Target Prediction database, the common targets of drugs and diseases database were conducted by GeneCards database platform and the Venny platform. We screened the core targets of AS like threonine kinase1 (AKT1), mitogen-activated protein kinase 1 (MAPK1), sirtuin-1 (SIRT1), mechanistic target of rapamycin kinase (MTOR) by STRING database, and the key pathways involved PI3K-AKT and FoxO signaling pathway by KEGG pathway enrichment analysis. Besides, qRT-PCR revealed AS preconditioning significantly up-regulated the expression level of AKT1, SIRT1, MAPK1, and MTOR in model cells, and the effect was related to the regulation of FoxO and PI3K/AKT signaling pathway. In summary, AS showed significant antioxidant activity and its potential mechanism was regulating FoxO and PI3K/AKT signaling pathway.Entities:
Keywords: Ailanthus altissima Swingle; RAW264.7 cell; antioxidant activity; antioxidant mechanism; in vitro; network pharmacology
Year: 2021 PMID: 34966812 PMCID: PMC8710717 DOI: 10.3389/fvets.2021.784898
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Primers used for qRT-PCR.
|
|
| |
|---|---|---|
| GAPDH |
| (F)GGTTGTCTCCTGCGACTTCA |
| (R)TGGTCCAGGGTTTCTTACTCC | ||
| AKT1 |
| (F) ACAGCCTCCCTCCATCACTTCAG |
| (R) TACCCACAATCTACCTCCCACCATC | ||
| MTOR |
| (F) TCCATTCCGTCAGCAGCATTGTC |
| (R) TCAGCCACACTCCTCATCCTCAC | ||
| MAPK1 |
| (F) GGTATCCAGCACATGATCCACAGTC |
| (R) GCAAGCGTTCTACATCAAGTTACATCC | ||
| SIRT1 |
| (F) GGATGGCCAGACTTTGCAGC |
| (R) CACCAGGGTCCTGCATCCAT |
Figure 1Antioxidant activities of AS at different concentrations (A) DPPH radical scavenging activity of AS and VC. (B) Ferrous ion-chelating rate of AS and EDTA-2Na. (C) Hydroxyl radical scavenging activity of AS and VC. (D) Reducing power of AS and VC. Data are shown as the mean ± SD (n = 3) (Supplementary Table 4).
Figure 2The effect of H2O2 on the viability of RAW264.7 cells. Cells were treated with different concentrations of H2O2 for 24 h. The results were presented as the mean ± SE of three independent experiments. **P < 0.01 compared with normal cell group (Supplementary Table 9).
Figure 3The effect of AS on the viability of RAW264.7 cells. Cells were treated with different concentrations of AS for 24 h. The results were presented as the mean ± SE of three independent experiments. *P < 0.05 and **P < 0.01 compared with the normal cell group (Supplementary Table 8).
Figure 4The effect of AS on the viability of RAW264.7 cells induced by H2O2. Cells were treated with different concentrations of AS for 20 h. The positive control group and AS-treated groups were then exposed to H2O2 (400 μM) for 4 h. The results were presented as the mean ± SE of three independent experiments. *P < 0.05 compared with the normal cell group, **P < 0.01 compared with the normal cell group. #P < 0.05 compared with H2O2, ANOVA analyses (Supplementary Table 7).
Figure 5Evaluation of antioxidant enzyme activity and lipid peroxidation. (A) The effect of AS on the activity of SOD. (B) The effect of AS on the activity of CAT. (C) The effect of AS on the cellular concentration of MDA. (D) The effect of AS on the activity of GSH-Px. The results were expressed as the mean ± SE of three independent experiments. *P < 0.05 compared with the normal cell group, **P < 0.01 compared with the normal cell group. ##P < 0.01 compared with H2O2, ANOVA analyses (Supplementary Table 5).
Information of bioactive components of AS.
|
|
|
|
|
|---|---|---|---|
| HBIN003737 | 1981-81-3 | Hydroxyhopanone | 0.55 |
| HBIN004383 | 67392-96-5 | Stigmast-4-en-3-one | 0.55 |
| HBIN007288 | 149-91-7 | Gallic acid | 0.56 |
| HBIN008266 | 2034-74-4 | 3-Hydroxystigmast-5-en-7-one | 0.55 |
| HBIN012810 | 36450-02-9 | (6beta,24R)-6-Hydroxystigmast-4-en-3-one | 0.55 |
| HBIN015955 | 559-70-6 | Amyrin | 0.55 |
| HBIN018278 | 83-46-5 | beta-Sitosterol | 0.55 |
| HBIN023517 | 514-07-8 | Taraxerone | 0.55 |
| HBIN025629 | 169567 | Erybidine | 0.55 |
| HBIN025688 | 5317205 | Erythraline | 0.55 |
| HBIN025690 | 442220 | Erythratidine | 0.55 |
| HBIN025796 | 305-01-1 | Esculetin | 0.55 |
| HBIN029763 | 34427-61-7 | Hydroxysitosterol | 0.55 |
| HBIN029818 | 487-58-1 | Hypaphorine | 0.55 |
| HBIN029831 | 9065764 | Hyperin | 0.55 |
| HBIN031753 | 520-18-3 | Kaempferol | 0.55 |
| HBIN035817 | 69-65-8 | Mannitol | 0.55 |
| HBIN041495 | 117-39-5 | Quercetin | 0.55 |
| HBIN044152 | 474-58-8 | Sitogluside | 0.55 |
| HBIN044849 | 113626-76-9 | Stigmast-4-ene-3,6a-diol | 0.55 |
| HBIN044850 | 23670-94-2 | Stigmast-4-ene-3,6-dione | 0.55 |
| HBIN044913 | 22149-69-5 | Stigmastane-3,6-dione | 0.55 |
| HBIN046124 | 14167-59-0 | Tetratriacontane | 0.55 |
| HBIN047613 | 77-52-1 | Ursolic acid | 0.85 |
| HBIN047744 | 121-33-5 | Vanillin | 0.55 |
| HBIN048051 | 14985 | Vitamin E | 0.55 |
Figure 6Antioxidant targets of AS interaction network.
Key targets of AS antioxidant PPI network.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| 1 | Threonine kinase1 (AKT1) | 106 | 2 | Interleukin 6 (IL-6) | 87 |
| 3 | Mitogen-activated protein kinase 3 (MAPK3) | 81 | 4 | Mitogen-activated protein kinase 1 (MAPK1) | 79 |
| 5 | Tumor necrosis factor (TNF) | 78 | 6 | Epidermal growth factor receptor (EGFR) | 73 |
| 7 | SRC proto-oncogene (SRC) | 70 | 8 | Signal transducer and activator of transcription 3 (STAT3) | 66 |
| 9 | Mitogen-activated protein kinase 8 (MAPK8) | 66 | 10 | C-X-C motif chemokine ligand 8 (CXCL8) | 64 |
| 11 | Sirtuin-1 (SIRT1) | 64 | 12 | Prostaglandin-endoperoxide synthase 2 (PTGS2) | 64 |
| 13 | Mechanistic target of rapamycin kinase (MTOR) | 59 | 14 | Strogen receptor 1 (ESR1) | 58 |
Figure 7Histogram of GO enrichment analysis of antioxidant targets in AS.
Figure 8Bubble chart of KEGG pathway enrichment analysis of antioxidant targets in AS.
Figure 9The expression level of core genes. (A) The expression level of AKT1 mRNA. (B) The expression level of MAPK1 mRNA. (C) The expression level of SIRT1 mRNA. (D) The expression level of MTOR mRNA. The results were expressed as the mean ± SE of three independent experiments. *P < 0.05 vs. 0, **P < 0.01 vs. 0. #P < 0.05 vs. H2O2, ##P < 0.01 vs. H2O2, ANOVA analyses (Supplementary Table 10).
Figure 10How AS exerts antioxidant effects.